/ /

Laird Harrison
Lifestyle modifications may help control glaucoma progression
Yvonne Ou, MD, gives patients advice about physical activity, body positions to avoid, leafy green vegetables, caffeine, and blood pressure treatment–as suggestions to help patients control their glaucoma progression.
New world order of glaucoma presenting strong challenges
Changes in both technology and the healthcare policy are presenting new challenges for glaucoma specialists. As the demand for eye care surges, ophthalmologists are struggling to keep up–despite the availability of better tools for diagnosis and treatment.
Artificial intelligence will bring ‘reality’ to glaucoma diagnosis
Robert Chang, MD, outlines how artificial intelligence might work in glaucoma.
Ebola may leave retinal scar
The Ebola virus may leave a retinal scar specific to the disease, according to researchers. “The distribution of these retinal scars or lesions provides the first observational evidence that the virus enters the eye via the optic nerve to reach the retina in a similar way to West Nile virus,” said Dr Paul Steptoe of the Royal Liverpool Hospital, in a press release.
Glaucoma monitoring implant receives CE mark
An implantable glaucoma sensor has received CE mark approval for marketing in the European Union. The sensor (Eyemate, Implandata Ophthalmic Products) can provide frequent IOP readings, informing patients and their physicians about how the pressure changes by time of day and from one day to another.
NICE recommends dexamethasone adalimumab for uveitis
The UK’s National Institute for Health and Care Excellence (NICE) has given preliminary approval to dexamethasone 0.7 mg intravitreal implant (Ozurdex, Allergan) and adalimumab (Humira, AbbVie) for sight-threatening non-infectious posterior uveitis.
Vitrectomy beats scleral buckling in rhegmatogenous retinal detachment study
Eyes operated on with pars plana vitrectomy needed fewer reoperations over 180 days than eyes subjected to scleral buckling (SB) in a retrospective comparison of patients with rhegmatogenous retinal detachment (RRD).
Researchers image single cell deaths in glaucoma patients
A new imaging technique can show the deaths of individual cells in people with glaucoma by labelling the cells with fluorescent dye, according to researchers. The approach might eventually be used to diagnosis the disease in its early stages or measure its progression.
Posterior IOLs effective in keratoconus
Posterior chamber phakic IOLs can correct refractive errors associated with keratoconus and can also be combined with other surgical techniques when necessary, according to researchers.
Rituximab appears to cure Mooren’s ulcers in 5 patients
Mooren’s ulcers completely healed in 5 patients treated with rituximab after conventional treatment failed, according to researchers.